ロード中...
Potential Pitfalls of Crossover and Thoughts on Iniparib in Triple-Negative Breast Cancer
As recruitment for oncology clinical trials has become more difficult, there appears to have been an increase in the number of studies that allow patients in the control arm to “crossover” and receive the experimental therapy after disease progression. Although some researchers worry that allowing s...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3247787/ https://ncbi.nlm.nih.gov/pubmed/22045362 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djr386 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|